Galena Biopharma Inc. (GALE)

5.72
0.00 (0.00)
NASDAQ : Health Technology
Prev Close 5.72
Open 5.72
Day Low/High 5.56 / 5.85
52 Wk Low/High 3.43 / 19.80
Volume 55.42K
Avg Volume 886.60K
Exchange NASDAQ
Shares Outstanding 45.71M
Market Cap 11.98M
EPS -2,128.20
P/E Ratio N/A
Div & Yield N.A. (N.A)
June 6th Options Now Available For Galena Biopharma (GALE)

June 6th Options Now Available For Galena Biopharma (GALE)

Investors in Galena Biopharma Inc saw new options become available today, for the June 6th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the GALE options chain for the new June 6th contracts and identified the following call contract of particular interest.

The Seven Deadly Sins of Biotech Investing

The Seven Deadly Sins of Biotech Investing

A fool and is money are soon parted, the old idiom goes. I'll add this: The money parting often happens faster to fools who invest in sketchy small-cap biotech stocks.

'Mad Money' Lightning Round: I'm Sticking With Con Ed

'Mad Money' Lightning Round: I'm Sticking With Con Ed

Cramer thinks STMicroelectronics is inexpensive but he's not crazy about Amazon or SodaStream.

Jim Cramer's 'Mad Money' Recap: How Stupid Can This Market Be?

Jim Cramer's 'Mad Money' Recap: How Stupid Can This Market Be?

Cramer thinks higher interest rates are bad for consumers and bad for the markets, not the other way around.

SEC Casting Wide Net in Galena Investigation

SEC Casting Wide Net in Galena Investigation

Lion Bio received an SEC subpoena related to the Galena DreamTeam investigation.

Biotech Stock Mailbag: Sarepta, F-R Rule Stock Predictions, Merrimack

Biotech Stock Mailbag: Sarepta, F-R Rule Stock Predictions, Merrimack

Biotech columnist Adam Feuerstein answers readers' questions about health care companies.

GALENA BIOPHARMA, INC. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors Of Class Action Against GALENA BIOPHARMA, INC. And Its Board And A Lead Plaintiff Deadline Of May 5, 2014

GALENA BIOPHARMA, INC. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors Of Class Action Against GALENA BIOPHARMA, INC. And Its Board And A Lead Plaintiff Deadline Of May 5, 2014

Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the District of Oregon on behalf of holders of Galena Biopharma, Inc.

First Week of June 21st Options Trading For Galena Biopharma (GALE)

First Week of June 21st Options Trading For Galena Biopharma (GALE)

Investors in Galena Biopharma Inc saw new options begin trading this week, for the June 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the GALE options chain for the new June 21st contracts and identified one put and one call contract of particular interest.

Lieff Cabraser Reminds Galena Biopharma, Inc. Investors Of Upcoming Deadline In Class Action Litigation – GALE

Lieff Cabraser Reminds Galena Biopharma, Inc. Investors Of Upcoming Deadline In Class Action Litigation – GALE

Lieff Cabraser Heimann & Bernstein, LLP reminds investors of the May 5, 2014 deadline to move for appointment as lead plaintiff in the securities class litigation brought on behalf of those who purchased or ...

GALENA BIOPHARMA, INC. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors Of Class Action Against GALENA BIOPHARMA, INC. And Its Board And A Lead Plaintiff Deadline Of May 5, 2014 -- GALE

GALENA BIOPHARMA, INC. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors Of Class Action Against GALENA BIOPHARMA, INC. And Its Board And A Lead Plaintiff Deadline Of May 5, 2014 -- GALE

Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the District of Oregon on behalf of holders of Galena Biopharma, Inc.

SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Galena Biopharma, Inc. To Contact Brower Piven Before The May 5, 2014 Lead Plaintiff Deadline

SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Galena Biopharma, Inc. To Contact Brower Piven Before The May 5, 2014 Lead Plaintiff Deadline

Brower Piven, A Professional Corporation announces that a class action lawsuit has been commenced in the United States District Court for the District of Oregon on behalf of purchasers of Galena Biopharma, Inc.

Hagens Berman Reminds Galena Biopharma, Inc. Investors Of May 5, 2014, Lead Plaintiff Deadline And Continued Securities Fraud Investigation

Hagens Berman Reminds Galena Biopharma, Inc. Investors Of May 5, 2014, Lead Plaintiff Deadline And Continued Securities Fraud Investigation

Hagens Berman Sobol Shapiro LLP reminds investors of the May 5, 2014, deadline to file for lead plaintiff in a securities fraud case against Galena Biopharma, Inc.

Today's Dead Cat Bounce Stock: Galena Biopharma (GALE)

Today's Dead Cat Bounce Stock: Galena Biopharma (GALE)

Trade-Ideas LLC identified Galena Biopharma (GALE) as a "dead cat bounce" (down big yesterday but up big today) candidate

Cohen Milstein Sellers & Toll PLLC Announces The Investigation Of Galena Biopharma, Inc.

Cohen Milstein Sellers & Toll PLLC Announces The Investigation Of Galena Biopharma, Inc.

Cohen Milstein Sellers & Toll PLLC is conducting an investigation to determine whether Galena Biopharma, Inc.

First Week of May 17th Options Trading For Galena Biopharma (GALE)

First Week of May 17th Options Trading For Galena Biopharma (GALE)

Investors in Galena Biopharma Inc saw new options become available this week, for the May 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the GALE options chain for the new May 17th contracts and identified one put and one call contract of particular interest.

These Stocks Are Getting Hit Hardest During March's Biotech 'Correction'

These Stocks Are Getting Hit Hardest During March's Biotech 'Correction'

Geron, Celldex Therapeutics, Xoma and Cytrx are among the drug stocks losing more than 30% of their value in the past month.

Lieff Cabraser Announces Class Action Litigation Against Galena Biopharma, Inc. - GALE

Lieff Cabraser Announces Class Action Litigation Against Galena Biopharma, Inc. - GALE

The law firm of Lieff Cabraser Heimann & Bernstein, LLP announces that class action litigation has been brought on behalf of those who purchased or otherwise acquired the securities of Galena Biopharma, Inc.

Biotech Stock Mailbag: Amarin, Cytrx, Sangamo and 'Story Stocks'

Biotech Stock Mailbag: Amarin, Cytrx, Sangamo and 'Story Stocks'

Biotech columnist Adam Feuerstein answers readers' questions about health care companies.

March 28th Options Now Available For Galena Biopharma (GALE)

March 28th Options Now Available For Galena Biopharma (GALE)

Investors in Galena Biopharma Inc saw new options become available today, for the March 28th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the GALE options chain for the new March 28th contracts and identified the following put contract of particular interest.

Trade-Ideas: Galena Biopharma (GALE) Is Today's "Perilous Reversal" Stock

Trade-Ideas: Galena Biopharma (GALE) Is Today's "Perilous Reversal" Stock

Trade-Ideas LLC identified Galena Biopharma (GALE) as a "perilous reversal" (up big yesterday but down big today) candidate